Source: International Congress 2017 – Current challenges in COPD evaluation
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
M. Labor (Zagreb, Croatia). Predicting future development of COPD (MARKO study). 398

Member's Comments

No comment yet.

Related content which might interest you: The Northjutland COPD prevention study (NCPS) Source: Eur Respir J 2006; 28: Suppl. 50, 447s Year: 2006 Identifying a ‘frequent exacerbator‘ phenotype in a cohort of COPD patients (EXACO study) Source: Annual Congress 2012 - Prevalences and characterstics of obstructive airway disease Year: 2012 Implications of under treatment of stable COPD (SAVING study) Source: International Congress 2015 – New data on established treatments for COPD Year: 2015 Characterization and functional progression of COPD in young adults (early COPD) Source: Annual Congress 2013 –Diagnosis and management of respiratory diseases Year: 2013 Characteristics of COPD in never smokers: results from the international burden of obstructive lung disease (BOLD) study Source: Annual Congress 2008 - Epidemiology of respiratory symptoms and COPD Year: 2008 An integrated care management program (ICMP) for patients with severe COPD; mortality, hazards and causes Source: International Congress 2015 – Best abstracts in chronic care Year: 2015 Comparison of gender-related risk factors for COPD – Results from the Canadian obstructive lung disease (CanCOLD) study Source: Annual Congress 2013 –Factors associated with outcomes in COPD Year: 2013 Health status predicts long-term outcomes in patients with chronic obstructive pulmonary disease (COPD): Pooled analysis of patient-level data from the COPD biomarker qualification consortium database Source: International Congress 2015 – Notable abstracts in exacerbations, mechanisms and biomarkers in COPD Year: 2015 Risk of future exacerbations among COPD patients – a real-world register-based cohort study (AvoidEx) Source: Virtual Congress 2020 – Airflow obstruction, COPD and comorbidities Year: 2020 COPD screening and risk factor frequency identification study Source: Annual Congress 2013 –Disease control and quality of life in airway diseases Year: 2013 Complexity in chronic asthma and COPD: implications for risk assessment, disease progression and control Source: Annual Congress 2008 - A step-change in asthma. The Lancet/ERS symposium Year: 2008 Development of a new prognosis index (BODS) in patients with COPD:a prospective cohort study Source: International Congress 2018 – What’s hot in rehabilitation in COPD and interstitial lung disease (ILD)? Year: 2018 Stable state MR-proadrenomedullin level in COPD patients; a validation study Source: International Congress 2014 – Comorbidities Year: 2014 The Northjutland COPD follow-up prevention study (NCPS) Source: Annual Congress 2010 - Risk factors, prevalence and consequences of COPD Year: 2010 What should be part of a comprehensive assessment of COPD? Source: International Congress 2016 – Best abstracts in COPD management Year: 2016 Mathematical model to predict the risk of future exacerbations in non-smoking patients with COPD Source: International Congress 2016 – Phenotyping and monitoring airway diseases Year: 2016 Decline in function in preclinical COPD patients: a 6 years follow up study. Source: International Congress 2017 – Assessing the functional status of patients with COPD Year: 2017 Validation of the COPD control concept: A UK pilot Source: International Congress 2016 – Comorbidities and exacerbations in COPD Year: 2016 Risk scores for predicting death in COPD patients Source: International Congress 2016 – Highlights in the management of COPD and beyond Year: 2016 Change of COPD maintenance medication over two years in a large real life cohort: The DACCORD study Source: International Congress 2016 – In-patient and out-patient COPD management Year: 2016